PLM-101 is an anticancer compound orally active against acute myeloid leukemia by targeting FLT3 and RET. It impedes RET function, promoting autophagic breakdown of FLT3, and suppresses the PI3K and Ras/ERK pathways, contributing to its anti-leukemic eff
Molecular Weight:
407.44
Formula:
C22H22FN5O2
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
